1
|
Miranda DAG, Cerqueira ARA, Muscará MN, Severino B, Caliendo G, Corvino A, Andreozzi G, Scognamiglio A, Chorilli M, Frecentese F, Costa SKP, Lopes LB. Development and evaluation of nanostructured systems for cutaneous delivery of H 2S-releasing corticosteroids for skin inflammatory diseases. Eur J Pharm Sci 2024; 203:106925. [PMID: 39374744 DOI: 10.1016/j.ejps.2024.106925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2024] [Revised: 08/30/2024] [Accepted: 10/04/2024] [Indexed: 10/09/2024]
Abstract
Psoriasis is an immune-mediated chronic inflammatory disease that causes major psychosocial impact. Topical corticosteroids represent the standard pharmacological treatment for mild-to-moderate disease, but their local and systemic adverse effects reinforce the need for treatment innovations. Here we developed lamellar phase-based formulations for topical delivery of a hybrid dexamethasone and hydrogen sulfide (H2S) donor molecule (Dexa-TBZ), aiming to potentiate the effects of the glucocorticoid with H2S. They offer the possibility to obtain precursor formulations free of water that originate lamellar phases upon water addition, preventing drug hydrolysis during storage. Two groups of formulations were developed varying the surfactants and oil phase types and content. Systems containing 20 and 70 % of water formed, respectively, bulk lamellar phase and a more fluid formulation consisting of dispersed droplets (< 1000 nm) stabilized by lamellar phase. Both presented pseudoplastic behavior. Dexa-TBZ was incorporated at 1 %, remaining stable for 8 h. Drug content decreased to ∼80 % after 1 week in precursor formulations free of water, but remained stable after that. Without causing changes to the cutaneous barrier function ex vivo or to the histological structure of the skin in vivo, the formulation containing phosphatidylcholine as surfactant and 70 % of water promoted 1.8- and 2.7-fold increases in Dexa-TBZ penetration in the stratum corneum and epidermis+dermis, respectively, compared to a control solution, demonstrating their potential applicability as topical delivery systems.
Collapse
Affiliation(s)
- Daniel A G Miranda
- Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil
| | - Anderson R A Cerqueira
- Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil
| | - Marcelo N Muscará
- Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil
| | - Beatrice Severino
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples 80131, Italy
| | - Giuseppe Caliendo
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples 80131, Italy
| | - Angela Corvino
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples 80131, Italy
| | - Giorgia Andreozzi
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples 80131, Italy
| | - Antonia Scognamiglio
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples 80131, Italy
| | - Marlus Chorilli
- School of Pharmaceutical Sciences, São Paulo State University, Araraquara, SP, Brazil
| | - Francesco Frecentese
- Department of Pharmacy, School of Medicine, University of Naples Federico II, Naples 80131, Italy
| | - Soraia K P Costa
- Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil
| | - Luciana B Lopes
- Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil.
| |
Collapse
|
2
|
Tucker IG, Jain R, Alawi F, Nanjan K, Bork O. Translational studies on a ready-to-use intramuscular injection of penethamate for bovine mastitis. Drug Deliv Transl Res 2018; 8:317-328. [PMID: 28512690 DOI: 10.1007/s13346-017-0388-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Bovine mastitis caused by bacterial infections of the mammary gland (udder) of dairy cows is a costly pathology for the dairy industry due to direct and indirect losses in production. Penethamate, a pro-drug of benzylpenicillin, is used by intramuscular injection (IM). The existing products are powders which must be reconstituted in water-for-injection and this presents difficulties in the field. Penethamate is too unstable to be formulated as an aqueous formulation but a chemically stable suspension formulation was possible in certain oils; however, some literature suggests that such formulations would have unacceptable prolonged release. The translational research proceeded iteratively from lab to the target species, rather than via laboratory animal trials. Pilot studies in cows suggested that some oily suspensions would give concentrations of benzylpenicillin, (in both blood and milk) comparable with those of the reconstituted product. A physicochemical screen and a low level in vitro-in vivo correlation (IVIVC) was cautiously used to guide selection of formulations for subsequent animal trials which have resulted in a lead formulation for good laboratory practices (GLP), good clinical practices (GCP) studies.
Collapse
Affiliation(s)
- I G Tucker
- School of Pharmacy, University of Otago, P.O. Box 56, Dunedin, 9010, New Zealand.
| | - R Jain
- School of Pharmacy, University of Otago, P.O. Box 56, Dunedin, 9010, New Zealand
| | - F Alawi
- APAC Development Centre, Bayer New Zealand Limited, 3 Argus Place, Hillcrest, Auckland, 0627, New Zealand
| | - K Nanjan
- APAC Development Centre, Bayer New Zealand Limited, 3 Argus Place, Hillcrest, Auckland, 0627, New Zealand
| | - O Bork
- School of Pharmacy, University of Otago, P.O. Box 56, Dunedin, 9010, New Zealand
| |
Collapse
|
3
|
Jain R, Bork O, Alawi F, Nanjan K, Tucker IG. An observational study of the effect of vibration on the caking of suspensions in oily vehicles. Int J Pharm 2016; 514:308-313. [PMID: 27863677 DOI: 10.1016/j.ijpharm.2016.05.037] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2016] [Revised: 05/19/2016] [Accepted: 05/20/2016] [Indexed: 12/01/2022]
Abstract
An oily suspension of penethamate (PNT) that was physically stable on storage, caked solidly during road/air transport. This paper reports on the caking behaviour of PNT oily suspension formulations exposed to vibrations in a lab-based test designed to simulate road/air transport. The lab-test was used to study the effects of container type (glass v PET) and formulation (oil, surfactant type and concentration) on the physical stability of suspension under vibration. Redispersibility of the sediment was lower at longer vibrations times and at higher intensity of vibration. Caking on vibration was strongly influenced by the type of container (caking in glass but not in PET) possibly due to tribo-charging of particles. Caking on vibration was dependent on the formulation: type and concentration of surfactant; type of oil. The physical stability of oily suspensions, and the effect of vibration are two areas which have been largely neglected in the pharmaceutical literature. This paper discusses some potential mechanisms for the observations but studies using fully characterised materials are required. Finally we conclude that static testing of physical stability of oily suspensions is not sufficient and that a vibrational stress test is required.
Collapse
Affiliation(s)
- Rohit Jain
- School of Pharmacy, University of Otago, P.O. Box 56, Dunedin, 9010, New Zealand
| | - Olaf Bork
- School of Pharmacy, University of Otago, P.O. Box 56, Dunedin, 9010, New Zealand
| | - Fadil Alawi
- APAC Development Centre, Bayer New Zealand Limited, 3 Argus Place, Hillcrest, Auckland 0627, New Zealand
| | - Karthigeyan Nanjan
- APAC Development Centre, Bayer New Zealand Limited, 3 Argus Place, Hillcrest, Auckland 0627, New Zealand
| | - Ian G Tucker
- School of Pharmacy, University of Otago, P.O. Box 56, Dunedin, 9010, New Zealand.
| |
Collapse
|
4
|
Talaczyńska A, Lewandowska K, Garbacki P, Zalewski P, Skibiński R, Miklaszewski A, Mizera M, Cielecka-Piontek J. Solid-state stability studies of crystal form of tebipenem. Drug Dev Ind Pharm 2015; 42:238-44. [DOI: 10.3109/03639045.2015.1044902] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- Alicja Talaczyńska
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland,
| | | | - Piotr Garbacki
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland,
| | - Przemysław Zalewski
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland,
| | - Robert Skibiński
- Department of Medicinal Chemistry, Medical University of Lublin, Lublin, Poland, and
| | - Andrzej Miklaszewski
- Institute of Materials Science and Engineering, Poznan University of Technology, Poznan, Poland
| | - Mikołaj Mizera
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland,
| | - Judyta Cielecka-Piontek
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Poznań, Poland,
| |
Collapse
|